These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19493005)

  • 41. Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis.
    Hermida Lazcano I; Sáez Méndez L; Solera Santos J
    J Infect; 2005 Dec; 51(5):e257-9. PubMed ID: 15951018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rare red rash.
    Hashmi S; Heidari A; Jeng A
    Am J Med; 2008 Oct; 121(10):862-3. PubMed ID: 18823855
    [No Abstract]   [Full Text] [Related]  

  • 43. Brucella diskitis mimicking herniation without spondylitis; MRI findings.
    Demirci I
    Zentralbl Neurochir; 2003; 64(4):178-81. PubMed ID: 14634883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brucella Melitensis As Causative Agent for Neck Abscess in an Endemic Area.
    Sarrou S; Skoulakis C; Hajiioannou J; Petinaki E; Bizakis I
    Balkan Med J; 2017 Jan; 34(1):78-80. PubMed ID: 28251029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management.
    Wareth G; Dadar M; Ali H; Hamdy MER; Al-Talhy AM; Elkharsawi AR; Tawab AAAE; Neubauer H
    Transbound Emerg Dis; 2022 Sep; 69(5):e1253-e1268. PubMed ID: 35244335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Transverse myelitis caused by Brucella].
    Sánchez Chaparro MA; Mérida de la Torre FJ; González Alegre P; González Santos P
    Rev Clin Esp; 1999 Nov; 199(11):778. PubMed ID: 10638250
    [No Abstract]   [Full Text] [Related]  

  • 47. Rifampin induced arthritis.
    Azap OK; Arslan H; Timurkaynak F
    J Infect; 2005 Oct; 51(3):261-2. PubMed ID: 16125781
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors.
    Kutlu M; Ergin Ç; Şen-Türk N; Sayin-Kutlu S; Zorbozan O; Akalın Ş; Şahin B; Çobankara V; Demirkan N
    J Infect Dev Ctries; 2015 Feb; 9(2):141-8. PubMed ID: 25699488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen.
    Pappas G; Seitaridis S; Akritidis N; Tsianos E
    Int J Antimicrob Agents; 2004 Nov; 24(5):502-7. PubMed ID: 15519485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.
    Cisneros JM; Viciana P; Colmenero J; Pachón J; Martinez C; Alarcón A
    Antimicrob Agents Chemother; 1990 May; 34(5):881-3. PubMed ID: 2193624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An aerosolized Brucella spp. challenge model for laboratory animals.
    Olsen SC; Waters WR; Stoffregen WS
    Zoonoses Public Health; 2007; 54(8):281-5. PubMed ID: 17894637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis.
    Mohammadi Azad Z; Moravej H; Fasihi-Ramandi M; Masjedian F; Nazari R; Mirnejad R; Moosazadeh Moghaddam M
    J Med Microbiol; 2017 Jul; 66(7):919-926. PubMed ID: 28699872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new variant of Brucella melitensis.
    Lucero NE; Ayala SM; Escobar GI; Grayon M; Jacques I
    Clin Microbiol Infect; 2006 Jun; 12(6):593-6. PubMed ID: 16700714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Doxycycline].
    Bonnetblanc JM
    Ann Dermatol Venereol; 2002; 129(6-7):874-82. PubMed ID: 12218915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of neurobrucellosis: what is known and what remains to be answered.
    Pappas G; Akritidis N; Christou L
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):983-90. PubMed ID: 18039082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [In vitro sensitivity to five antibiotics of clinical isolated Brucella spp].
    Efron A; Lopardo H; Lucero NE
    Rev Argent Microbiol; 1999; 31 Suppl 1():56-7. PubMed ID: 10509415
    [No Abstract]   [Full Text] [Related]  

  • 58. [A brucellosis case with macular rash and peripheral neuropathy].
    Kaya S; Kostakoğlu U
    Mikrobiyol Bul; 2009 Jan; 43(1):147-51. PubMed ID: 19334392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
    Ariza J; Bosilkovski M; Cascio A; Colmenero JD; Corbel MJ; Falagas ME; Memish ZA; Roushan MR; Rubinstein E; Sipsas NV; Solera J; Young EJ; Pappas G; ;
    PLoS Med; 2007 Dec; 4(12):e317. PubMed ID: 18162038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemical and biological factors in the control of Brucella and brucellosis.
    Gamazo C; Lecároz MC; Prior S; Vitas AI; Campanero MA; Irache JM; Blanco-Prieto MJ
    Curr Drug Deliv; 2006 Oct; 3(4):359-65. PubMed ID: 17076637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.